Physician profile
Santa Dalessio
NPI 1275591919
$15,048.49
in general payments reported to CMS, 2019-2025
22 companies · $63.05 in 2025
The $63.05 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,467 · 2020: $5,189 · 2021: $2,017 · 2022: $1,219 · 2023: $1,093 · 2025: $63.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081 · Education: $75.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.82 |
| Education | $75.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $9,960.16 | 2019-2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $1,537.45 | 2019-2023 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $732.12 | 2019-2023 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $606.69 | 2019-2023 | Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $542.74 | 2021-2023 | Dupixent |
| Inspire Medical Systems, INC. | $392.08 | 2021-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $247.52 | 2019-2022 | |
| Grifols USA, LLC | $166.76 | 2019-2023 | Prolastin-C Liquid |
| Baxter Healthcare | $163.73 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $122.99 | 2019-2023 | Tyvaso |
| Genentech USA, INC. | $117.78 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $112.24 | 2019-2021 | |
| Genzyme Corporation | $90.53 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $61.04 | 2021-2023 | |
| Philips North America LLC | $59.79 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.66 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $21.52 | 2019 | |
| Insmed, INC. | $18.32 | 2021 | |
| Electromed, INC. | $16.34 | 2022 | |
| Advanced Respiratory, INC | $14.26 | 2020 | |
| Stryker Corporation | $13.71 | 2023 | Focess Hd Wireless Camera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santa Dalessio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.